Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CMT1A”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Not applicableStudy completedNCT01750710
What this trial is testing

Correlation Between Clinical and Electrophysiological Phenotypes in a Population of Patients With Neuropathy Charcot-Marie-Tooth Disease Type 1A

Who this might be right for
Charcot-Marie-Tooth Type 1A Neuropathy
University Hospital, Clermont-Ferrand 37
Testing effectiveness (Phase 2)Study completedNCT01401257
What this trial is testing

Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A

Who this might be right for
Charcot-Marie-Tooth DiseaseHereditary Neuropathy With Liability to Pressure PalsiesGenetic Disorders
Pharnext S.C.A. 80
Not applicableLooking for participantsNCT07476365
What this trial is testing

A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease (CMT1A)

Who this might be right for
CMTCMT (Charcot Marie Tooth Disease)CMT - Charcot-Marie-Tooth Disease+2 more
University Medical Center Goettingen 70
Not applicableLooking for participantsNCT07049588
What this trial is testing

Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease

Who this might be right for
Charcot-Marie-Tooth Disease Type 1A
Assistance Publique Hopitaux De Marseille 55
Testing effectiveness (Phase 2)Looking for participantsNCT06328712
What this trial is testing

Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A(CMT1A) (Phase 1b: Open-label, Dose-escalation, Single-center; Phase 2a: Randomized, Double-blind, Placebo-controlled, Multicenter)

Who this might be right for
Charcot-Marie-Tooth Disease Type 1A
ENCell 27
Not applicableStudy completedNCT03715283
What this trial is testing

Change in MUNIX in Patients With CMT1A Undergoing a Home Ankle Strengthening Program Versus Standard of Care

Who this might be right for
Charcot-Marie-Tooth Disease
Vanderbilt University Medical Center 19
Not applicableActive Not RecruitingNCT02596191
What this trial is testing

Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers

Who this might be right for
Charcot-Marie-Tooth Disease Type 1A
Assistance Publique Hopitaux De Marseille 80
Not applicableStudy completedNCT05142059
What this trial is testing

Fall Risk Assessment in a Population of Charcot-Marie-Tooth Disease Type 1A (CMT 1A) by Timed Up and Go Test

Who this might be right for
Charcot-Marie-Tooth Type 1A Neuropathy
University Hospital, Clermont-Ferrand 42
Not applicableLooking for participantsNCT01193088
What this trial is testing

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

Who this might be right for
Charcot-Marie-Tooth Disease, Type Ia (Disorder)HMSN
University of Iowa 1,050
Not applicableLooking for participantsNCT07570446
What this trial is testing

AUTONOMOUS DISORDERS IN CMT

Who this might be right for
CMT - Charcot-Marie-Tooth DiseaseCMT1ACMT (Charcot Marie Tooth Disease)
University Medical Center Goettingen 50
Testing effectiveness (Phase 2)Study completedNCT05361031
What this trial is testing

The Safety and Tolerability of Engensis (VM202) in Patients With Charcot-Marie-Tooth Disease Subtype 1A (CMT1A)

Who this might be right for
CMT
Helixmith Co., Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT02967679
What this trial is testing

SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study

Who this might be right for
Chronic Inflammatory Demyelinating PolyneuropathyPeripheral NeuropathyCharcot-Marie-Tooth Disease+3 more
MedDay Pharmaceuticals SA 15
Large-scale testing (Phase 3)UnknownNCT01289704
What this trial is testing

Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot-Marie-Tooth Neuropathy Type 1A (CMT1A)

Who this might be right for
Charcot-Marie-Tooth DiseaseCharcot-Marie-Tooth Disease Type 1A
University of Genova 92
Testing effectiveness (Phase 2)Not Yet RecruitingNCT03520751
What this trial is testing

Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A

Who this might be right for
Charcot-Marie-Tooth Neuropathy Type 1A
Nationwide Children's Hospital 3
Testing effectiveness (Phase 2)Ended earlyNCT02600286
What this trial is testing

Ulipristal Acetate In Disease Charcot-Marie-Tooth Type of 1A

Who this might be right for
CMT1A
University Hospital, Strasbourg, France 23
Testing effectiveness (Phase 2)Study completedNCT00271635
What this trial is testing

Ascorbic Acid Treatment in CMT1A Trial (AATIC)

Who this might be right for
Charcot-Marie-Tooth DiseaseHereditary Motor and Sensory Neuropathies
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 13
Not applicableStudy completedNCT03386266
What this trial is testing

Biomarkers and Validation of Selected Outcome Measures (CMTBiomarker)

Who this might be right for
Charcot-Marie-Tooth Disease, Type IA
University Medical Center Goettingen 156
Large-scale testing (Phase 3)Study completedNCT02579759
What this trial is testing

Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)

Who this might be right for
Charcot-Marie-Tooth Disease Type 1A
Pharnext S.C.A. 323
Not applicableUnknownNCT03278093
What this trial is testing

Effect of Orthoses and Underfoot Vibration on Balance in Neuropathy

Who this might be right for
CMT - Charcot-Marie-Tooth DiseasePeripheral NeuropathyHereditary Peripheral Neuropathy+1 more
St George's, University of London 15
Large-scale testing (Phase 3)UnknownNCT03023540
What this trial is testing

Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A

Who this might be right for
Charcot-Marie-Tooth Disease, Type IA
Pharnext S.C.A. 187
Load More Results